Literature DB >> 2023870

Nebulization of liposomes. II. The effects of size and modeling of solute release profiles.

R W Niven1, M Speer, H Schreier.   

Abstract

A series of carboxyfluorescein (CF)-containing multilamellar vesicle (MLV) dispersions was prepared and extruded through polycarbonate membranes ranging in size from 0.2 to 5 microns. Vesicle dispersions were nebulized for 80 min using a Collison nebulizer, and the release of CF was monitored during nebulization. Solute retention was dependent upon the size of the vesicles and leakage ranged from 7.9 +/- 0.4% (N = 3) for vesicles extruded through 0.2-microns filters to 76.8 +/- 5.9% (N = 3) for liposomes that were not filtered. Solute release profiles obtained over greater than or equal to 420-min nebulization periods conformed to a two-compartment kinetic model and exhibited a "fast" initial phase (k1 = 0.052 +/- 0.0043) followed by a "slow" terminal phase (k2 = 0.0034 +/- 0.00018). The results show that CF retention can be increased by nebulizing small vesicles and modeling suggests that the rate of CF leakage from the bilayers is faster than from the core of the liposomes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2023870     DOI: 10.1023/a:1015896121377

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Inaccurate calculation of drug output from nebulisers.

Authors:  C O'Callaghan; A R Clarke; A D Milner
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

2.  Techniques for encapsulating bioactive agents into liposomes.

Authors:  L D Mayer; M B Bally; M J Hope; P R Cullis
Journal:  Chem Phys Lipids       Date:  1986 Jun-Jul       Impact factor: 3.329

3.  Operating characteristics of some compressed-air nebulizers.

Authors:  T T Mercer; M I Tillery; H Y Chow
Journal:  Am Ind Hyg Assoc J       Date:  1968 Jan-Feb

4.  Continuous aerosol therapy system using a modified Collison nebulizer.

Authors:  H W Young; J W Dominik; J S Walker; E W Larson
Journal:  J Clin Microbiol       Date:  1977-02       Impact factor: 5.948

Review 5.  Clinical aerosols. I. Characterization of aerosols and their diagnostic uses.

Authors:  R V Lourenço; E Cotromanes
Journal:  Arch Intern Med       Date:  1982-11

6.  Evaluation of jet nebulisers for use with gentamicin solution.

Authors:  S P Newman; P G Pellow; M M Clay; S W Clarke
Journal:  Thorax       Date:  1985-09       Impact factor: 9.139

7.  Nebulization of liposomes. I. Effects of lipid composition.

Authors:  R W Niven; H Schreier
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

8.  Changes in salbutamol concentration in the reservoir solution of a jet nebulizer.

Authors:  J A Wood; R S Wilson; C Bray
Journal:  Br J Dis Chest       Date:  1986-04

9.  Small particle aerosols of enviroxime-containing liposomes.

Authors:  B E Gilbert; H R Six; S Z Wilson; P R Wyde; V Knight
Journal:  Antiviral Res       Date:  1988-09       Impact factor: 5.970

  9 in total
  8 in total

Review 1.  Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medications.

Authors:  N R Labiris; M B Dolovich
Journal:  Br J Clin Pharmacol       Date:  2003-12       Impact factor: 4.335

Review 2.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

3.  A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation.

Authors:  Aileen Gibbons; Noel G McElvaney; Sally-Ann Cryan
Journal:  AAPS PharmSciTech       Date:  2010-09-15       Impact factor: 3.246

4.  Initial characterization of micafungin pulmonary delivery via two different nebulizers and multivariate data analysis of aerosol mass distribution profiles.

Authors:  Shuai Shi; Elizabeth S Dodds Ashley; Barbara D Alexander; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2009-02-03       Impact factor: 3.246

5.  Unilamellar vesicles as potential capreomycin sulfate carriers: preparation and physicochemical characterization.

Authors:  Stefano Giovagnoli; Paolo Blasi; Claudia Vescovi; Giuseppe Fardella; Ione Chiappini; Luana Perioli; Maurizio Ricci; Carlo Rossi
Journal:  AAPS PharmSciTech       Date:  2004-12-31       Impact factor: 3.246

6.  Nebulization of liposomes. III. The effects of operating conditions and local environment.

Authors:  R W Niven; T M Carvajal; H Schreier
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

Review 7.  Inhaled chemotherapy in lung cancer: future concept of nanomedicine.

Authors:  Paul Zarogoulidis; Ekaterini Chatzaki; Konstantinos Porpodis; Kalliopi Domvri; Wolfgang Hohenforst-Schmidt; Eugene P Goldberg; Nikos Karamanos; Konstantinos Zarogoulidis
Journal:  Int J Nanomedicine       Date:  2012-03-22

Review 8.  Liposomes as nanomedical devices.

Authors:  Giuseppina Bozzuto; Agnese Molinari
Journal:  Int J Nanomedicine       Date:  2015-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.